<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>34</Volume>
      <Issue>3-4</Issue>
      <PubDate PubStatus="epublish">
        <Year>1996</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">FLUORESCENCE IN SITU HYBRIDIZATION IN IRANIAN PATIENTS WITH PRIMARY BREAST CANCER</title>
    <FirstPage>80</FirstPage>
    <LastPage>82</LastPage>
    <AuthorList>
      <Author>
        <FirstName></FirstName>
        <LastName>P. Mehdipour</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>M. Atri</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Breast cancer is preservative of the genetic heterogeneous alterations. In the present investigation, fluorescence in situ hybridization (FISH) was performed on the fresh primary tumours of 6 patients with infilterating ductal carcinoma. DNA-probe for centromere of chromosome 3 (3cen) was applied and in the total analysis, the majority of interphases presented 1 signal (33.6%) which followed by 3 (28,8%), 2 (16.8%) and 4 (13.5%) signals. Only two tomours showed the +presence of more than 6 signals. The presence of 2 signals could be observed in only one tumour (19.6%). In two tumours, 3 signals (33.1%) was considered as the most frequent alteration and followed by more than 6 signals (25.5% and 18.3% respectively), in tumour ID 27, and 3 signals (43.1%) followed by 1 and 4 signals (30.1% and 17.2% respectively) in tumour ID 33. It is concluded that the FISH-technique is able to clarify and diagnose the numerical alterations of chromosome 3 cen in tumour cells of BC patients.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/1699</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/1699/1692</pdf_url>
  </Article>
</Articles>
